Biotech Daily - Uscom in Focus, page-5

Towards 40c ... Well I think there's way more than that in it. Given that Mr Meng has tipped (and is likely, still tipping) his own money into the business. His well credentialed medical access to 10.000 hospitals across China speaks volumes for what can happen in the blink of an eye (your 40c). So be careful about targets. Insofar that, taking profits can be rewarding at times, but it may result in disappointment later. To wit, I well remember here when a bright poster at HC declared with great confidence he would re-jump back into CAN when they dropped to sub 80c. Poor sod, took up a few scraps in profits and thought it was marvelous. Yet right now, way less than a year after the company floated back in May, the price momentarily flicked $4 .. Indeed, providing just a little hint of what lies in wait

With Uscom, the guiding light should be sales. Hard evidence the China market responds to one of their own - Mr Meng. Anyway, its my view he's here for good reason